Hologic (NASDAQ:HOLX) Downgraded by Citigroup
Hologic (NASDAQ:HOLX – Get Free Report) was downgraded by research analysts at Citigroup from a “buy” rating to a “neutral” rating in a research report issued on Tuesday, Marketbeat Ratings reports. They currently have a $85.00 target price on the medical equipment provider’s stock, down from their prior target price of $95.00. Citigroup’s price target […]
3 Oct 08:34 · The Markets Daily